Pediatric refractory partial status epilepticus responsive to topiramate

Journal of Child Neurology

Volumn 20, Issue 3, 2005, Pages 239-241

  Blumkin, Lubov ^a,b   Lerman Sagie, Tally ^a,b   Houri, Tzion ^a,b   Gilad, Eli ^a,b   Nissenkorn, Andrea ^a,b   Ginsberg, Mira ^a,b   Watemberg, Nathan ^a,b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CLOBAZAM; GABAPENTIN; IMMUNOGLOBULIN; METHYLPHENIDATE; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; TOPIRAMATE; VIGABATRIN;

ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CHILD HEALTH CARE; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG ERUPTION; DRUG MEGADOSE; DRUG SAFETY; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NASOGASTRIC TUBE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME; VASCULITIS;

EID: 17644402453     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738050200031701     Document Type: Article

References (21)

1. Mitchell W: Status epilepticus and acute serial seizures in children. J Child Neurol 2002; 17(Suppl 1): S36-S43.
2. Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002;59:205-210.
3. Gilbert DL, Gartside PS, Glauser TA: Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: A meta-analysis. J Child Neurol 1999;14:602-609.
4. Singhi S, Banerjee S, Singhi P: Refractory status epilepticus in children: Role of continuous diazepam infusion. J Child Neurol 1998;13:23-26.
5. Sahin M, Menache CC, Holmes GL, Riviello JJ: Outcome of severe refractory status epilepticus in children. Epilepsia 2001;42:1461-1467.
6. Kim SJ, Lee DY, Kim JS: Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr Neurol 2001; 25:217-220.
7. Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR: Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology 1988;38:1035-1040.
8. Hauser WA: Status epilepticus: Epidemiologic consideration. Neurology 1990;40(Suppl 2):9-13.
9. Maytal J, Shinnar S, Moshe SL, Alvarez LA: Low morbidity and mortality of status epilepticus in children. Pediatrics 1989;83: 323-331.
10. Holmes GL, Riviello J Jr: Midazolam and pentobarbital for refractory status epilepticus. Pediatr Neurol 1999;20:259-264.
11. Pellock JM: Use of midazolam for refractory status epilepticus in pediatric patients. J Child Neurol 1998;13:581-587.
12. Towne AR, Pellock D, Ko D, DeLorenzo RJ: Determinants of mortality in status epilepticus. Epilepsia 1994-135:27-34.
13. Neibauer M, Gruenthal M: Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res 1999;837:263-269.
14. Towne AR, Garnett LK, Waterhouse EJ, et al: The use of topiramate in refractory status epilepticus. Neurology 2003;60:332-334.
15. Kahriman M, Minecan D, Kutluay E, et al: Efficacy of topiramate in children with Epilepsia 2003;44:1353-1356.
16. Bleck TP: Advances in the management of refractory status epilepticus. Crit Care Med 1993;21:955-957.
17. Lowenstein DH, Alldredge BK: Status epilepticus at an urban public hospital in the 1980s. Neurology 1993;43:483-488.
18. Singhi S, Murthy A, Singhi P, Jayashree M: Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol 2002; 17:106-110.
19. Bleck PB: Refractory status epilepticus in 2001. Arch Neurol 2002;59:188-189.
20. Glauser TA, Clarke PO, Strawsburg R: A pilot study of topiramate in the treatment of infantile spasms. Epilepsia 1998;39:1324-1328.
21. Watemberg N, Goldberg-Stern H, Ben-Zeev B, et al: Clinical experience with open-label topiramate use in infants younger than 2 years of age. J Child Neurol 2003;18:258-262.